Cg1.Ax

CG1.AX has a debt-to-equity ratio of 1.61, indicating a capital structure that is significantly leveraged, with liabilities exceeding equity. The company's liquidity position is weak, as evidenced by a current ratio of 0.23, suggesting that it may struggle to meet short-term obligations without external financing.

Profitability is a major concern, with a negative return on equity of -73.31% and a return on assets of -20.95%. These figures are well below the typical performance of the Commodity Chemicals industry, which usually sees positive returns, and indicate that the company is not generating value for shareholders or effectively utilizing its assets.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, and there is no indication of geographic diversification in the provided data. This lack of diversification increases the company's exposure to regional economic downturns or supply chain disruptions.

Looking ahead, the company is expected to see a decline in revenue, as the most recent actual revenue of 12,327,090 AUD is significantly lower than the reported revenue of 16,195,340 AUD. This suggests a challenging operating environment, potentially driven by weak demand or pricing pressures in the chemical sector.

The company faces several risk factors, including liquidity constraints and the potential for dilution, although the latter is currently assessed as low. The negative operating and free cash flows, combined with a high debt load, suggest that the company may need to raise additional capital or restructure its debt in the near future.

Recent financial filings indicate a deteriorating financial position, with a net loss of 6,761,390 AUD and a negative operating income of 3,426,370 AUD. These results highlight the need for operational improvements or strategic changes to restore profitability and stabilize the company's financial health.